Home / Companies / News / Possible to make new Covid strain vax in 100 days: Gennova BioPharma

Possible to make new Covid strain vax in 100 days: Gennova BioPharma

Co gets nod for Omicron booster of its mRNA vaccine

Premium

Gennova Biopharmaceuticals

Sohini Das Mumbai

4 min read Last Updated : Jun 20 2023 | 8:26 PM IST

Listen to This Article

Pune-based Gennova BioPharmaceuticals, which developed the country’s first mRNA vaccine and has now obtained approval for a mix-and-match booster dose based on the Omicron strain of the Sars-CoV-2 virus, says it can make a new vaccine based on an emerging strain within 100-days, if need be.

Speaking to the media, Sanjay Singh, CEO, Gennova said the firm was in discussions with the Coalition for Epidemic Preparedness Innovations (CEPI) on the matter. “Developing a vaccine on any new strain within 100 days is feasible, and globally such discussions are on. We are also in discussions with CEPI on this matter. Whether

Topics : Coronavirus Coronavirus Vaccine

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in